BioSpace News Archive

Bio-Techne Corporation (NASDAQ: TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has reported results from a proof-of-concept study for a novel exosome-based platform that could monitor key biological changes in astronauts in space.

RedHill Biopharma Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency.

Results of a third clinical study reveal that Arjuna Natural Pvt. Ltd.'s Rhuleave-K ® is also effective in pain relief at a dosage 50% that of the previous two studies.

Adapsyn Bioscience Inc. today announced that it has received funding from the Bill & Melinda Gates Foundation to find novel therapeutics that target tuberculosis (TB).

Veeva Systems (NYSE: VEEV) today announced the availability of Veeva CDB, a first-of-its-kind solution for aggregating, cleaning, and transforming clinical data.

Veeva Systems (NYSE: VEEV) today announced the availability of Veeva ePRO , a key advancement in patient-centric digital trials.

Sonendo, Inc. today announced the release of the GentleWave G4 System, the next generation of its innovative technology platform designed to treat tooth decay.

BioIntelliSense Acquires AlertWatch ® Clinical Intelligence Engine to Expand its Comprehensive Portfolio of Continuous Patient Monitoring Solutions.

Today Reveleer, a healthcare technology company using intelligent automation to empower data-driven healthcare for payers in all lines of business, announced the launch of NLP First Pass for Quality, an Artificial Intelligence (AI)-assisted abstraction solution for health plans and risk-bearing providers nationwide.

Ikena Oncology, Inc. today provided a research & development update on the Company’s lead targeted oncology program in TEAD inhibition.